Page 1,200«..1020..1,1991,2001,2011,202..1,2101,220..»

Construction Equipment Rental Market Healthy Pace throughout the Forecast during 2026 – Crypto News Byte

Posted: Published on December 4th, 2019

Global Contrast Injector Marketwas valued US$ 447.2 Mn in 2017 and is expected to reach US$ 812.6 by 2026, at a CAGR of 7.75% during a forecast period. Continue reading →

Posted in Interventional Cardiology | Comments Off on Construction Equipment Rental Market Healthy Pace throughout the Forecast during 2026 – Crypto News Byte

Europe Inflation Device Market 2019: Analysis By Growing Demand, Product and Process, Key Companies, Trends, Regional-Outlook and Forecast Till 2026 -…

Posted: Published on December 4th, 2019

Market Definition: Inflation devices are designed & developed to inflate and deflate the catheters and stents while performing various procedures. These devices are used to measure the pressure in stents and balloons during various cardiac, urological, gastrointestinal surgeries. Continue reading →

Posted in Interventional Cardiology | Comments Off on Europe Inflation Device Market 2019: Analysis By Growing Demand, Product and Process, Key Companies, Trends, Regional-Outlook and Forecast Till 2026 -…

Inflation Device Market Booming Demand for Growing Ageing Population at Highest CAGR with Major Players | Acclarent, Inc., Accura, SMT, Elite Medtek…

Posted: Published on December 4th, 2019

Global inflation device market is projected to register a steady CAGR of 4.5% in the forecast period of 2019 to 2026. Inflation Device Market report presents the company profiles of the key vendors and comprehensively analyzes their core competencies to increase an adaptive perspective on the competitive scene and helps the readers to plan the strategies accordingly-: Acclarent, Inc., Accura, SMT, Elite Medtek (Jiangsu) Co. Ltd, Atrion Corporation, US Endovascular, Smiths Group plc, Nucryo Vascular LLC, Spectrum Medtech Pvt. Continue reading →

Posted in Interventional Cardiology | Comments Off on Inflation Device Market Booming Demand for Growing Ageing Population at Highest CAGR with Major Players | Acclarent, Inc., Accura, SMT, Elite Medtek…

St. Joseph Mercy Ann Arbor named one of the nation’s 50 Top Cardiovascular Hospitals in 2020 – thesuntimesnews.com

Posted: Published on December 4th, 2019

Advertisement | 2 min read | from St. Joseph Mercy | St. Joseph Mercy Ann Arbor has been named one of the nations 50 Top Cardiovascular Hospitals by IBM Watson HealthTM Continue reading →

Posted in Interventional Cardiology | Comments Off on St. Joseph Mercy Ann Arbor named one of the nation’s 50 Top Cardiovascular Hospitals in 2020 – thesuntimesnews.com

Avinger (NASDAQ:AVGR) and ABIOMED (NASDAQ:ABMD) Head to Head Analysis – Mitchell Messenger

Posted: Published on December 4th, 2019

Avinger (NASDAQ:AVGR) and ABIOMED (NASDAQ:ABMD) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings. Continue reading →

Posted in Interventional Cardiology | Comments Off on Avinger (NASDAQ:AVGR) and ABIOMED (NASDAQ:ABMD) Head to Head Analysis – Mitchell Messenger

BioVentrix Announces Publication of Positive One-Year Outcomes for Revivent TC System – Yahoo Finance

Posted: Published on December 4th, 2019

Study Published in European Journal of Heart Failure Shows Significant and Sustained Improvement in Heart Function, Symptom Relief and Quality of Life Using Less Invasive Left Ventricular Enhancement Device BioVentrix, Inc., developer of the first less invasive system for left ventricular remodeling, today announced online publication of positive one-year results from its CE Mark study of the Revivent TC System in the European Journal of Heart Failure. The paper will be published in print in the January issue of the journal. Authors of the study, entitled "Less Invasive Ventricular Reconstruction for Ischemic Heart Failure" concluded, "Treatment with the Revivent TC System in patients with symptomatic heart failure results in significant and sustained reduction of left ventricular (LV) volumes and improvement of LV function, symptoms, and quality of life." They added, "The ability to achieve these results without the need for sternotomy or cardiopulmonary bypass is an important advance for the treatment of patients suffering from ischemic cardiomyopathy heart failure." The prospective, multicenter, single-arm study of 89 patients at 22 centers in 12 countries in the European Union was designed to evaluate the efficacy and safety of the Revivent TC System for scar exclusion in the heart, volume reduction, and reshaping of the LV in selected patients with ischemic cardiomyopathy (enlarged and weakened left ventricle with reduced capacity to pump blood after a heart attack) Continue reading →

Posted in Ventricular Remodeling | Comments Off on BioVentrix Announces Publication of Positive One-Year Outcomes for Revivent TC System – Yahoo Finance

Patients With Chemotherapy-Induced Cardiomyopathy Show Improvements in LVEF After Cardiac Resynchronization Therapy – AJMC.com Managed Markets Network

Posted: Published on December 4th, 2019

Maggie L. Shaw Heart issues in patients with cancer and survivors can present themselves months or years after treatment Continue reading →

Posted in Ventricular Remodeling | Comments Off on Patients With Chemotherapy-Induced Cardiomyopathy Show Improvements in LVEF After Cardiac Resynchronization Therapy – AJMC.com Managed Markets Network

Testosterone Replacement Therapy Market to See Admirable Grrowth by 2024 According to a New Research Report – Kentucky Reports

Posted: Published on December 3rd, 2019

The global market for testosterone replacement therapy is characterized by the presence of a large number of small and large scale manufacturers. All of the manufacturers have been steadfast in filling the meagre market gap in order to enhance their prospects of growth Continue reading →

Posted in Testosterone | Comments Off on Testosterone Replacement Therapy Market to See Admirable Grrowth by 2024 According to a New Research Report – Kentucky Reports

Expanded U.S. NATETSO Partnership Between Acerus Pharmaceuticals and Aytu BioScience Is Now Fully Operational – Financial Post

Posted: Published on December 3rd, 2019

TORONTO Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB:ASPCF) today announced that the revised commercial partnership agreement with Aytu Bioscience (Aytu) to accelerate the growth of NATESTO in the United States is now closed and fully effective as of December 1, 2019. Both parties have mutually waived the closing conditions of the revised partnership agreement, including the requirement that Acerus complete a raise of a minimum of USD 10 million on or before the end of January 2020, enabling Acerus to launch a U.S.-based specialty sales force, which will promote NATESTO to urologists and endocrinologists. Aytu will continue to book all NATESTO revenue in the United States and they will promote NATESTO to all other specialties including internal medicine and family practice Continue reading →

Posted in Testosterone | Comments Off on Expanded U.S. NATETSO Partnership Between Acerus Pharmaceuticals and Aytu BioScience Is Now Fully Operational – Financial Post

The Wolf of Wall Street Immersive Experience, review: an overlong scenario with the barely contained testosterone of a stag party – inews

Posted: Published on December 3rd, 2019

CultureArts Of all the groups you probably wouldnt want to be part of, the hyper-adrenalised, hardscrabble populace of Jordan Belfort's memoir is one Friday, 29th November 2019, 4:44 pm An immersive theatre adaptation of Jordan Belfort's memoir Of all the groups you probably wouldnt want to be part of, surely the hyper-adrenalised, hardscrabble populace of The Wolf of Wall Street, the Jordan Belfort memoir made into an amphetamine rush of a film by Martin Scorsese in 2013, must rank near the very top. Continue reading →

Posted in Testosterone | Comments Off on The Wolf of Wall Street Immersive Experience, review: an overlong scenario with the barely contained testosterone of a stag party – inews

Page 1,200«..1020..1,1991,2001,2011,202..1,2101,220..»